Episode Details

Back to Episodes
Discussing AxSpA: Long-Term Outcomes of Secukinumab & JAKis in Clinical Practice

Discussing AxSpA: Long-Term Outcomes of Secukinumab & JAKis in Clinical Practice

Published 1 year, 9 months ago
Description
Join us for the latest axSpA podcast brought to you by the Immune-mediated Inflammatory Disease forum! This month Dr Sofia Ramiro is joined by Professors Hideto Kameda and Xenofon Baraliakos to discuss the long-term impact of secukinumab treatment on bone-related outcomes and BTMs in r-AxSpA patients over two years. Our faculty then move on to discuss another publication, which presents JAKi treatment recommendations for IMIDs from a two-round modified RAM study with 21 subject matter experts.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us